Eupatorin has been reported with in vitro cytotoxic effect on several human cancer cells. However, reports on the mode of action and detail mechanism of eupatorin in vitro in breast cancer disease are limited. Hence, eupatorin's effect on the human breast carcinoma cell line MCF-7 and MDA-MB-231 was investigated. MTT assay showed that eupatorin had cytotoxic effects on MCF-7 and MDA-MB-231 cells but was non-toxic to the normal cells of MCF-10a in a time-dose dependent manner. At 24 h, the eupatorin showed mild cytotoxicity on both MCF-7 and MDA-MB-231 cells with IC 50 values higher than 20 μg/mL. After 48 h, eupatorin at 5 μg/mL inhibited the proliferation of MCF-7 and MDA-MB-231 cells by 50% while the IC 50 of MCF-10a was significantly (p < 0.05) high with 30 μg/mL. The concentration of eupatorin at 5 μg/mL induced apoptosis mainly through intrinsic pathway by facilitating higher fold of caspase 9 compared to caspase 8 at 48 h. The cell cycle profile also showed that eupatorin (5 μg/ mL) exerted anti-proliferation activity with the cell cycle arrest of MCF-7 and MDA-MB-231 cells at sub Gθ/G1 in a time-dependent manner. In addition, wound healing assay showed an incomplete wound closure of scratched MDA-MB-231 cells, and more than 60% of the MDA-MB-231 cells were prevented to migrate and invade the membrane in the Boyden chamber after 24 h. Eupatorin also inhibited angiogenic sprouting of new blood vessels in ex vivo mouse aorta ring assay. In gene expression assay, eupatorin up-regulated pro-apoptotic genes such as Bak1, HIF1A, Bax, Bad, cytochrome c and SMAC/ Diablo and blocked the Phospho-Akt pathway.
Results
Eupatorin inhibited proliferation of human breast adenocarcinoma MCF-7 and MDA-MB-231 cells. Cytotoxic effect of eupatorin on MCF-7 and MDA-MB-231 cells was evaluated using MTT assay. As shown in Supplementary Fig. 1 (A-C), eupatorin caused a time (24, 48 and 72 h) and dosage (0.16-20 μg/mL) dependent inhibition of cell proliferation towards MCF-7 and MDA-MB-231 (Table 1) . At 24 h, the IC 50 value of eupatorin was higher than 20 μg/mL for both cell types. When the incubation was extended for 48 h, the MCF-7 and MDA-MB-231 cells exhibited the IC 50 value of 5 μg/mL. At 72 h, the IC 50 of MCF-7 and MDA-MB-231 cells was 3 μg/mL and 2 μg/mL, respectively. In contrast, eupatorin was recorded with much lower cytotoxic effect to MCF-10a cells, which exhibited high IC 50 value of 30 μg/mL at 72 h.
The selectivity Index (SI) in Table 1 shows that cytotoxic effects of eupatorin were selected towards MCF-7 and MDA-MB-231 cells where the SI value of 6 was recorded for respective cells type at 48 h, respectively. Interestingly, these values were 6.5 and 8.8 times higher than the positive control doxorubicin. Subsequently, the IC 50 value of eupatorin at 48 h (5 μg/ml) was selected to treat MCF-7 and MDA-MB-231 cells in further experiments.
Morphological assessment. Phase contrast microscopy. As shown in Fig. 1A -C, the untreated MCF-7 and MDA-MB-231 cells maintained their original morphology and close contact to each other even when the incubation was prolonged to 72 h. In contrast, the MCF-7 and MDA-MB-231 cells lost their original shape at 24 h of eupatorin treatment. The MCF-7 cells were not in their polygonal or trigonal shape while MDA-MB-231 cells had lost their elongated spindle-shape morphology. When the treatment was extended to 48 h, suspension cells (dead cells) were identified and more suspension cells were observed at 72 h (Fig. 1B,D) .
Morphological changes of MCF-7 and MDA-MB-231 cells apoptosis by SEM. Through SEM, morphological changes in MCF-7 and MDA-MB-231 cells were characterized in detail. The untreated MCF-7 cells ( Fig. 2A,B ) showed their intact membrane with its pseudopodia were at full stretch, tightly sticking on the cover glass while the untreated MDA-MB-231 cells ( Fig. 2E ,F) exhibited abundant microvilli and cellular crowding with cytoplasmic connection, which suggests healthy proliferation. However, morphologically damage cells were observed in the eupatorin treated MCF-7 and MDA-MB-231 groups at 24 h (Fig. 2C,G) . When the treatment was extended to 72 h, MCF-7 cells were clearly shrunk to abnormal round ( Fig. 2D ) while MDA-MB-231 cells were shrunk and lost their microvilli (Fig. 2H) .
Eupatorin inhibited the migration and invasion of MDA-MB-231 cells. The effect of eupatorin on cell migration was examined using the scratch assay (Fig. 3A,B ). As shown in Fig. 3B , eupatorin (5 μg/mL) significantly (p < 0.05) decreased cell motility and migration of cancer cells where the complete closure of the scratched area was inhibited by 50.14% at 24 h. In addition, Transwell Boyden chamber assay showed that eupatorin prevented MDA-MB-231 cells from migrating aggressively through the filter (Fig. 3C,D) . Only 38 ± 3% of MDA-MB-231 cells migrated through the membrane compared to the untreated group (Fig. 3E ). In addition, Fig. 3F 3H ) at 24 h. Taken together, these results suggest that eupatorin has strong inhibitory effects on the migration and invasion of MDA-MB-231 cells.
Effects of eupatorin in angiogenic inhibition.
To study the role played by eupatorin in angiogenesis, mouse aortic rings assay was carried out using aorta isolated from Balb/c mice ( Fig. 3I ,J). As shown in Fig. 3J , mouse aorta ring of Balb/c mouse treated with eupatorin (5 μg/mL) exhibited a small amount of vascular sprouting of new blood vessels from the aorta as pointed out in red circle. In contrast, the green arrow pointed out the massive tube formation around the tissue section of the untreated mouse aorta ( Fig. 3I ). Sprouts from the control mouse aorta rings were longer in length and more branches were formed. Therefore, ex vivo model using aortic ring from Balb/c mouse suggests that eupatorin can act as an anti-angiogenic agent.
Effect of eupatorin on the cell cycle distribution in MCF-7 and MDA-MB-231 cells. The cell cycle analysis for control and treated MCF-7 ( Fig. 4A ) and MDA-MB-231 ( Fig. 4B ) was analyzed using a flow cytometer. The results showed that 34.40% ± 4.7 MCF-7 cells that were exposed to eupatorin for 24 h were arrested in the G2/M phase while 12.37% ± 1.51 of treated cells were distributed in S phase (Fig. 4C ). In addition, a small percentage of MCF-7 cells (5.89% ± 0.30) were in sub Gθ/G1 transition. On the other hand, Fig. 4D shows that 24.33% ± 4.37 of MDA-MB-231 cells were accumulated in the sub Gθ/G1 phase while cells in G2/M phase and S phase was 2.00% ± 0.09 and 10.73% ± 0.61 respectively. At 48 h treatment, the number of MCF-7 cells accumulated in sub Gθ/G1 was extremely increased to 27.52% ± 2.06 while cell in G2/M phase was 26.41% ± 5.48 whereas the number of MDA-MB-231 cells accumulated in sub Gθ/G1 was remarkably high which exhibited 42.75% ± 4.67. When the treatment was prolonged to 72 h, the number of MCF-7 cells arrested in G2/M phase was 30.06% ± 0.56 while cells accumulated in sub Gθ/G1 slightly decreased to 23.99% ± 0.13. For MDA-MB-231 cells, the cells percentage in sub Gθ/G1 was slightly decreased to 37.54% ± 2.82. However, the number of cells arrested in S phase was increased to 17.13% ± 0.88. These data showed that eupatorin can act both as apoptosis inducer and cells growth inhibitor in MCF-7 and MDA-MB-231 cells in a time dependent manner. Caspase activity in eupatorin-treated MCF-7 and MDA-MB-231 cells. Figure 6C demonstrates the activation of caspases activity including caspase 3/7, 8 and 9 in MCF-7 and MDA-MB-231 cells at 48 h treatment with eupatorin. Based on this figure, activation of caspase 9 was higher than caspase 8 in both types of cancer cells. Caspase 9 possessed 1.29 ± 0.02 fold while caspase 8 exhibited 1.11 ± 0.06 fold in MCF-7 cells. In MDA-MB-231 cells, caspase 8 and 9 were up-regulated to 2.23 ± 0.11 fold and 3.57 ± 0.15, respectively.
Eupatorin altered the expression in cell cycle/checkpoint. In this study, regulation of protein expression in cell cycle for MDA-MB-231 and MCF-7 cells such as beta-actin (housekeeping protein), retinoblastoma (Rb-Raf-1), checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) was analyzed. The protein band is shown in Fig. 7A . Based on Fig. 7B , eupatorin altered the protein levels in MCF-7 and MDA-MB-231 cells. The levels of Cdc2 molecules in MDA-MB-231 cells were reduced to 0.971 fold by eupatorin at dose of 5 μg/mL for 48 hours. In contrast, eupatorin enhanced the regulation of the expression of Chk1 (1.473), Chk2 (1.352) and Rb-Raf-1 (12.575), which belong to cell cycle stimulating molecules. Meanwhile, the protein expression of Chk1 and Chk2 in MCF-7 cells was suppressed by 5 μg/mL eupatorin at 48 hours incubation. In contrast, the protein of Cdc2 and Rb-Raf-1 in MCF-7 cells were enhanced by 1.290 and 6.123 fold at 48 hours of eupatorin treatment. Therefore, these results indicated that eupatorin may inhibit cells proliferation through depletion of Cdc2 protein in MDA-MB-231 and dysregulation of Chk1 protein level in MCF-7 cell cycle checkpoint to weaken invasion and migration in breast cancer cells through angiogenesis. 
Discussion
Eupatorin is a methoxyflavone, a group of flavonoid that shows great potential as cancer chemopreventive agents in cell culture studies 11, 15 . It is known as an anti-proliferation and anti-mitotic flavonoid 10 . To be a potent anti-cancer in biological system, a flavone should consist of methoxy groups that metabolize faster to the conversion products than their hydroxylated analogues 16 . Previously, the anti-proliferative effects of eupatorin were proposed as a result of CYP1 family (cytochrome P450 CYP1) enzyme metabolism 9 . CYP1A1, CYP1A2 and CYP1B1 are the members of human CYP1 family enzymes that participated in phase I metabolism of drugs in the liver 17, 18 .
Overexpression of CYP1A1 and CYP1B1 were reported in various types of cancer cells including breast cancer 19 . Eupatorin, which possesses the structural features (being planar, neutral, and aromatic), makes it fit in well within CYP1A2 cavity 20 . Other studies have documented that besides CYP1A2, eupatorin also can be metabolized by CYP1A1 and CYP1B1. These CYP1 families promoted hydroxylation in eupatorin at 4′ position in the B ring with the presence of neighboring pre-existing substitution that were not hydroxylated to form flavone cirsiliol 9, 16 . The bioconversion of eupatorin to more active product such as cirsiliol enhanced the antiproliferative activity. Further hydroxylation by CYP1 family enzymes may occur within cirsiliol at 5′, 6′ and 8′ positions in A ring and at 5′ position in B ring, which may enhance the antiproliferative activity 16 . Importantly, CYP1 family enzymes were not expressed in MCF-10a cells 9 . Thus, eupatorin at 5 μg/mL did not affect the viability of human normal breast MCF-10a cells and was found highly selective towards cancer cells indicated by SI>3 21, 22 . Interestingly, although the IC 50 value of eupatorin was far higher than the common anticancer drug doxorubicin on both cancer cell lines, the MCF-10a vs MCF7 and MCF-10a vs MDA-MB-231 SI values of eupatorin were 6.5 and 8.8 times higher than doxorubicin, respectively. This result had shown the advantage and potential of further exploring the potential antitumor effect of eupatorin. Exposure of eupatorin to the pre-mitotic cells also caused defects in spindle structure and centrosome function that resulted in a mitotic delay in anaphase 10 . This triggered a transient M phase and potently induced apoptosis in multiple cancer cell lines that suppressed cancer cell proliferation 10 . During eupatorin treatment, breast cancer cells lost their epithelial properties including cell-cell contacts, degradation of microvilli and destruction of membrane cells. In the tumor microenvironment, elevated levels of MMPs such as MMP-9 were able to induce epithelial-mesenchymal-transition (EMT), whereas EMT itself promotes MMP-9 secretion that facilitates cell invasion and metastasis 23 . EMT is a cell process by which epithelial cells converse into mesenchymal cells and obtain the capacity of cell motility to maintain the invasion and metastasis of malignancies 24 . Hence, the knockdown of MMP-9 leads to down-regulation of EMT that inhibites the migration and invasion of aggressive breast cancer cells. Gene MMP-9 and VEGFA play a critical and dual role in cancer metastasis and angiogenesis to foster progression of breast cancer cells in vitro 25, 26 . Previous studies reported that gene of MMP9 is essential for cell migration 26 while VEGFA is a member of the family of platelet-derived growth factors, which is one of the primary pro-angiogenic factors that encourage the formation of new blood vessels in the tumour microenvironment [27] [28] [29] [30] [31] [32] . Thus, down-regulation of either MMP9 or VEGFA expressions could further suppress the metastatic potential and angiogenic of cancer cells 33 .
Reduction of MMP9 expression is commonly associated with the increase of mitochondrial membrane permeability, which facilitates the release of pro-apoptotic factors 34 . The activation of protein Bax, Bad, cytochrome c and SMAC/Diablo confirmed the activation of mitochondria mediated apoptotic pathway 35 . Protein of Bad and Bax interacted with and decreased the levels of Bcl-2 family, which indicates that eupatorin led to a shift from anti-apoptosis to pro-apoptosis by altering the functions of the proteins in the Bcl-2 family 35 . Bax protein oligomerized at the outer mitochondrial membrane and promoted the opening of the mitochondria permeability transition pore, leading to the release of cytochrome c and SMAC/Diablo into the cytosol 36 . The activation of SMAC/Diablo and cytochrome c helped to generate the final step of apoptosis by binding the anti-apoptotic protein of Bcl-2 family and allowing the initiation of downstream caspase such as caspase 3/7, 8 and 9 37 . The release of cytochrome c triggered the activation of caspase 9 through the formation of apoptosome 21, 38 . The activation of the initiator caspase 9 caused the cleavage of effectors caspase 3/7 which then activated DNase and caused DNA fragmentation in the nucleus to form necrotic cells 21, 39 . Apoptosis induced by eupatorin was mainly activated through intrinsic pathway due to higher fold of activated caspase 9 compared to caspase 8. In Western blot analysis, growth inhibition of MCF-7 and MDA-MB-231 cells by eupatorin incubation was demonstrated to occur due to inactivation of Akt signaling pathway. Akt signaling pathway was reported to play a pivotal role in tumorigenesis because it affected the growth and survival of cancer cells 40 . This pathway was In cell cycle/checkpoint, eupatorin altered the survival-related protein, including Rb-raf-1 interaction, Chk1, Chk2 and Cdc2 in the treated MCF-7 and MDA-MB-231 cells. Level of Rb-raf-1 interaction, Chk1 and Cdc2 expression ensures the cells survival, which relates to angiogenesis induction while Chk2 is a tumour suppressor and stimulated in response to DNA damage and replication blockage that occurred within the cancerous cells due to proliferation inhibition 42, 43 . Chk1 is the major cell-cycle checkpoint kinase mediating S-and G2-arrest in response to various genotoxic stresses 42 , which prevents the initiation of mitosis 37 . Previous study reported that Chk1 inhibition leads to major decrease in cell viability in triple negative breast cancer cell lines 42 . Hence, depletion of Chk1 protein expression induces a marked reduction of cell viability and led to mitotic catastrophe in cancer cells 42 .
Checkpoint network gene is commonly stimulated, resulting in DNA damage in order to stop the cell cycle and concurrently starts the DNA repair process 42 . Cdc2 protein is involved in maintaining the survival of cancer cells. Disruption of Cdc2 caused cell cycle arrest in the G2/M phase 37 . In contrast, Chk2 is a tumour suppressor and is stimulated to respond to DNA damage and replication blockage that occurs within the cancerous cells. Hence, inhibition of Chk1 and Cdc2 signal could delay cancer cells proliferation and concurrently stimulate Chk2 protein. These results propose that eupatorin may inhibit cells proliferation in MDA-MB-231 and MCF-7 cells through the depletion of Cdc2 and Chk1 protein levels respectively, followed by the activation of Chk2 protein 42, 44 . The induction of cell cycle arrest at a specific checkpoint, and thereby inducing apoptosis, is a common mechanism for the cytotoxic effects of anticancer drugs 21 .
Comparing the effect of eupatorin in MCF-7 and MDA-MB-231, the same IC 50 value were obtained from both cell lines after 48 hours of treatment. However, some different results were observed in the regulation of Akt and cell cycle pathways analysis. This effect may be a result of the predominant of CYP1A1 in MCF-7 and CYP1B1 MDA-MB-231 17, 45 . CYP1A1 was reported as a strong metabolizer of eupatorin to flavone cirsiliol 9, 16 , which may be the predominant metabolites that contributed to the cytotoxicity in MCF-7 cells. On the other hand, MDA-MB-231 that was predominantly with CYP1B1, was reported as a slow metabolizer of eupatorin, still observed with better cytotoxic effect at 72 hours and even slightly higher degree regulation of the Akt and cell cycle pathway that contributed to anti-invasion and anti-angiogentic effect of eupatorin. This result provides the clue that unmetabolized eupatorin targeting estrogen negative breast cancer cells show potential advantageous targeting characteristics of invasive breast cancer.
In conclusion, the efficacy of eupatorin as an agent that selectively inhibits proliferation of human breast cancer cells in vitro was remarkable. Eupatorin demonstrated the potential anti-breast cancer effect of a flavonoid compound through inhibition of proliferation, invasion, migration and angiogenesis of breast cancer cells in vitro. In addition, eupatorin down-regulated the pro-angiogenic genes and upregulated the pro-apoptotic genes in both MDA-MB-231 and MCF-7 cells through inhibiting the Akt and cell cycle pathways. These findings, particularly on the high selectivity on breast cancer cells and mechanism of action, may lead to further development of a potential flavone-based anticancer drug. Although most flavonoids are known to easily penetrate in vitro cultured cells 16 , their bioavailability in vivo usually decreases due to the capability of enzymes such as in the small intestine and in the liver metabolizing the bioactive compounds 15 . In addition, as CYP1A2 has been associated with hepatotoxicity and chemoresistant due to its effect in metabolizing various drugs including eupatorin 17, 46 , future studies on in vivo efficacy, pharmacokinetic and toxicity of eupatorin are required.
Materials and Methods
Cell lines and culture conditions. The MCF-7 cells were cultured in RPMI-1640 (Sigma, USA) while MDA-MB-231 was maintained in Dulbecco's modified eagle medium (Sigma, USA). The MCF-10a cells were cultured in the mixture medium of Ham's F-12 (Sigma, USA) and Dulbecco's modified eagle medium supplemented with 20 ng/mL epidermal growth factor (EGF), 10 μg/mL insulin, and 250 ng/μL hydrocortisone. All media were added with 10% (v/v) heat-inactivated foetal bovine serum (FBS) (PAA, Austria), penicillin (100 I.U/mL) and streptomycin (100 ng/mL) (PAA, Austria). The cells were cultured at 37 °C in a 90% humidified incubator with 5% CO 2 . When the cells were 80% confluent, they were sub-cultured to a fresh media.
Materials. Eupatorin and doxorubicin (Sigma-Aldrich, USA) were dissolved in DMSO (Sigma, USA) to prepare a master stock solution at a concentration of 1 mg/mL and stored in −20 °C before use. The working solution was freshly prepared in the complete culture medium.
Cytotoxicity assay. The cells were seeded at a concentration of 0.8 × 10 5 cells/mL into a 96-well plate.
Following overnight adherence, the cells were incubated with the medium alone or with a two-fold serial dilution of eupatorin starting with the highest concentration at 20 μg/mL for 24, 48 and 72 h respectively. Doxorubin tested for 48 h of incubation was served as positive control. Then, 20 μL MTT solution was added to each well and mixed. After 4 h, the supernatants were removed and 100 μL DMSO was added to each well to dissolve the precipitate. The cells viability was estimated by measuring absorbance at 570 nm using a Quant ELISA plate reader (Bio-tek Instruments, USA). The cell viability percentage was calculated based on the absorbance ratio between cell culture treated with eupatorin and the untreated control multiplied by 100 represents cell viability (percentage of control, %). Selectivity Index (SI) was calculated as the ratio of cytotoxicity (IC 50 ) on normal cells (MCF-10a) to cancer cells (MCF-7 and MDA-MB-231). The SI value higher than 3 suggested that the cytotoxic effect of eupatorin was selective towards MCF-7 cells and MDA-MB-231 21, 47 . Morphological assessment using SEM. The untreated and treated cells were cultured on a glass slip for 24, 48 and 72 h respectively, fixed in 2.5% glutaradehyde, and followed by fixing in 1% osmium tetroxide, washed with 0.1 M sodium cacodylate buffer, dehydrated with acetone, and followed by drying in critical point dryer (BAL-TEC CPD 030, CA). The samples was mounted to remove charging and sputtering using sputter coater (BAL-TEC SCD 005, CA). Morphological changes of cancer cells were viewed using Variable Pressure Scanning Electron Microscopy (VP-SEM, USA) at 200x and 1000x magnification.
Treatment of MCF
Scratched assay. A scratched area was created using a sterile 200 μL pipette tip on 90% confluence of serum starved cells. Then, the cells were incubated in complete growth medium (10% FBS) in the absence or presence of eupatorin (5 μg/mL) for 24 hours. Cells migrated into the wound surface were determined under microscope at various time points. The ratio of cell migration was calculated as the percentage of the remaining cell-free area compared with the area of the initial scratched area 48, 49 .
Transwell migration and invasion assay. Cell migration and invasion were assayed using Transwell (BD Biosciences, USA) with PET track-etched membranes. In brief, 5 × 10 3 serum-starved cells of MDA-MB-231 were resuspended in serum free medium and transferred into the upper chamber of each Transwell. For invasion assay, the upper compartment of Transwell chamber was coated with matrigel (630 μL) which was diluted in serum-free media in 1:3 ratio before the addition of serum-starved cells. Lower chambers contained fresh medium with the presence or absence of 5 μg/mL eupatorin as chemo-attractant. After left overnight, the cells remaining at the upper surface of the membrane were removed using a swab, whereas those cells that had migrated or invaded to the lower membrane surface were fixed with 100% methanol (1 h) and stained with crystal violet 0.5% (2 h). The number of MDA-MB-231 cells migrated and invaded through the filter was photographed and counted using a microscope (Nikon, Japan) at a magnification of 200x.
Annexin-FITC/propidium iodide double staining. Apoptosis assessment was conducted using flow cytometry to determine the phosphatidyl serine exposed apoptotic cells by Annexin V-FITC and propidium iodide (PI) double staining. The experiment was carried out according to the Life Technologies Apoptosis Assay protocol and the samples were analysed by flow cytometry within 1 hour using the FACSCalibur (Becton Dickinson, CA) in triplicate. Dot-plot graphs were used to illustrate the viable cells (the lower left quadrant), Mouse aorta ring assay. An ethical approval was applied for and approved by Institutional Animal Care and Use Committee (IACUC), Universiti Putra Malaysia (UPM), Serdang, Selangor (Ethical no: R009/2015). All animal procedures were performed according to a protocol approved by the IACUC of Universiti Putra Malaysia. A matrigel (150 μL) was allowed to solidify in 48-well plate. Then, mouse aortic endothelial cells were isolated from the aorta of Balb/c mice, using protocol described by Masson et al. 50 with slight modifications. Briefly, the fat and connective tissues were cleared in PBS-Pennstrep (1%) and cut into 1 mm length. The tissues were placed on the matrigel surface and sandwiched with another 150 μL matrigel. Next, 1.5 mL of eupatorin diluted in complete RPMI-1640 media was transferred into the well and incubated at 37 °C (5% CO 2 /95% air). After 10 days, the tissues were viewed under a microscope (Nikon, Japan) and the emergent angiogenic sprouts microvessels from mouse aortas were observed in culture respectively 51 .
Real-time PCR (qPCR) analysis. cDNA was prepared from MCF-7 and MDA-MB-231 cells. qPCR was performed using CFX96 Real-time system (BIO-RAD, USA) to quantify the relative mRNA expression levels of selected genes. Primers sequences for all genes were acquired from Natural Centre of Biotechnology Information (NCBI) database (National Library of Medicine, US) and was synthesized by Integrated DNA Technologies (IDT, USA) as presented in Supplementary Table 1 . Expression of targeted genes was determined using KAPA SYBR ® FAST qPCR Kit Master Mix (2x) Universal (KAPA Biosystems, USA). Thermal cycling was initiated at 95 °C for 2 minutes, followed by 40 cycles consisting of denaturation at 95 °C for 10 seconds and combined annealing/ extension steps at 60 °C for 25 second. A melting curve analysis was performed by gradually heating the samples from 70 °C to 95 °C with 0.5 °C increment per second while the fluorescence was measured continuously. The standard curve that possessed efficiency (E) ≥ 90% with linear regression (R 2 ) ≥ 0.980 was accepted for genes quantification. All data were normalized to the expression of the reference genes using the Bio-Rad CFX manager (version 3.1) software.
Western blot analysis. All antibodies used were purchased from QIAGEN Biotechnology Malaysia Sdn Bhd (Cell Signaling Technology, USA). Protein was extracted from cell lines using RIPA lysis buffer with a proteinase inhibitor. The protein lysates were separated by using 12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 12.5%) and soaked in Transfer/Towbin buffer for 15 minutes. After separation, proteins were transferred onto a nitrocellulose membrane, blocked with 5% BSA in a TBS/Tween and then probed with primary antibodies at 4 °C, overnight. Then, the membrane was washed three times with TBST and incubated with the species appropriate HRP-conjugated secondary antibody and anti-biotin, HRP-linked Antibody (at 1:1000-1:3000) to detect biotinylated protein markers. Then, the membrane was washed again with TBST. For protein detection and development, the membrane was incubated in 1x Red Alert prior to visualize a clear protein band.
Apoptotic proteome profiling. Protein lysate was extracted from MCF-7 and MDA-MB-231 cells and the total protein of cell lysates was determined using Bradford method. In proteome analysis, the targeted protein was identified using Proteome Profiles Human Apoptosis Array kit (R&D systems). The experiment was carried out according to the instruction provided by the manufacturer. The protein arrays on the membranes were scanned using ChemiDoc MP Imaging System (BIO-RAD, USA). The data were analyzed using Image Lab 4.1 software.
Quantification of caspase 3/7, 8 and 9. The untreated and treated cells of MCF-7 and MDA-MB-231
were stained with 1 µl of Red-IETD-FMK (caspase 8 or 9) or PI (caspase 3/7) 1 h. Then, the pellet was collected and re-suspended in 100 μL wash buffer. The fluorescence intensity was measured at excitation/emission (Ex/ Em) = 540/570 nm for caspase 8 and 9 while the fluorescence intensity at Ex/Em = 548/631 was measured for caspase 3 using a fluorescence spectrophotometer (Hitachi, Japan).
